Curis to Present at the Cowen and Company 33rd Annual Health Care Conference

[at noodls] – LEXINGTON, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Curis is hiring next, click here to view